GSM-779690T

· Acta Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSM-779690T, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants [Phase 1]